[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genedx Holdings Corp 333 Ludlow Street North Tower 6th Floor Stamford CT 06902 USA

www.genedx.com Employees: 1,300 P: 888-729-1206 F: 201-421-2010

Sector:

Medical

Description:

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

Key Statistics

Overview:

Market Capitalization, $K 2,529,288
Enterprise Value, $K 2,472,468
Shares Outstanding, K 29,823
Float, K 22,317
% Float 74.83%
Short Interest, K 6,289
Short Float 21.09%
Days to Cover 6.39
Short Volume Ratio 0.69
% of Insider Shareholders 25.17%
% of Institutional Shareholders 61.72%

Financials:

Annual Sales, $ 427,540 K
Annual Net Income, $ -21,020 K
Last Quarter Sales, $ 114,440 K
Last Quarter Net Income, $ -17,740 K
EBIT, $ -92,400 K
EBITDA, $ -67,180 K

Growth:

1-Year Return -34.50%
3-Year Return 1,731.75%
5-Year Return -70.86%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 08/03/26
Next Earnings Date 10/27/26
Earnings Per Share ttm 0.36
EPS Growth vs. Prev Qtr 103.57%
EPS Growth vs. Prev Year -98.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-33 on 05/04/23

WGS Ratios

Ratio
Price/Earnings ttm 239.82
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 4.12%
Return-on-Assets % 2.26%
Profit Margin % -4.92%
Debt/Equity 0.40
Price/Sales 6.02
Price/Cash Flow 37.67
Price/Book 10.54
Book Value/Share 8.19
Interest Coverage -0.91
60-Month Beta 1.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.